Shane Barton - 07 Jun 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Reporting relationship: VP & Corporate Controller
Issuer ticker: DTIL
Reported as of: 07 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2022, 16:26:15 UTC
Prior SEC filing: 09 Jun 2021
Next SEC filing: 24 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Shane Barton

Key filing fact

Shane Barton filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 09 Jun 2022.

Key facts

This page summarizes Shane Barton's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2022, 16:26.

Change

Previous filing in this sequence was filed on 09 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DTIL transaction

Common Stock

Options Exercise

Transaction value
Shares: +6,061
Change %: +228%
Price
Shares after: 8,720
Date: 07 Jun 2022
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DTIL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -6,061
Change %: -33%
Price: $0.000000
Shares after: 12,120
Date: 07 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,061
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.

Footnote F2

Each RSU represents a contingent right to receive one share of the Company's Common Stock.

Footnote F3

On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.